These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6639832)

  • 41. Metergoline and cyproheptadine suppress prolactin release by a non-5-hydroxytryptaminergic, non-dopaminergic mechanism.
    Besser GM; Delitala G; Grossman A; Yeo T
    Br J Pharmacol; 1980 Sep; 70(1):5-7. PubMed ID: 7426830
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Two novel agents affecting eating through an action on monoaminergic systems.
    Roncucci R; Miranda GF; Verry M
    Int J Obes; 1984; 8 Suppl 1():103-17. PubMed ID: 6549508
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of fenfluramine and ritanserin on prolactin response to insulin-induced hypoglycemia in obese patients: evidence for failure of the serotoninergic system.
    Bernini GP; Argenio GF; Vivaldi MS; Del Corso C; Sgrò M; Franchi F; Luisi M
    Horm Res; 1989; 31(3):133-7. PubMed ID: 2501208
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of vasoactive intestinal peptide and 5-HT2 receptor subtype in serotonin stimulation of basal and thyrotropin-releasing-hormone-induced prolactin release in vitro from rat pituitary cells.
    Apfelbaum ME
    Neuroendocrinology; 1998 Jan; 67(1):45-50. PubMed ID: 9485168
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blunted fenfluramine-evoked prolactin secretion in hypertensive rats.
    Stocker SD; Muldoon MF; Sved AF
    Hypertension; 2003 Oct; 42(4):719-24. PubMed ID: 12885788
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacological evidence of an interaction between serotonergic and dopaminergic neurons in the control of prolactin secretion in male rats.
    Quattrone A; Schettini G; Di Renzo GF; Preziosi P
    Arch Int Pharmacodyn Ther; 1979 Mar; 238(1):42-9. PubMed ID: 485703
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prolactin response to fenfluramine is independent of serotonin release.
    McCann UD; Hatzidimitriou G; Ricaurte GA
    Eur J Pharmacol; 1996 Sep; 312(2):R1-2. PubMed ID: 8894606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fenfluramine, p-chloroamphetamine and p-fluoroamphetamine stimulation of pituitary-adrenocortical activity in rat: evidence for differences in site and mechanism of action.
    McElroy JF; Miller JM; Meyer JS
    J Pharmacol Exp Ther; 1984 Mar; 228(3):593-9. PubMed ID: 6323674
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dexfenfluramine-induced prolactin release as an index of central synaptosomal 5-hydroxytryptamine during treatment with fluoxetine.
    Sommers DK; van Wyk M; Snyman JR
    Eur J Clin Pharmacol; 1994; 46(5):441-4. PubMed ID: 7957540
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute tryptophan depletion attenuates the prolactin response to d-fenfluramine challenge in healthy human subjects.
    Coccaro EF; Kavoussi RJ; Cooper TB; Hauger R
    Psychopharmacology (Berl); 1998 Jul; 138(1):9-15. PubMed ID: 9694521
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Role of the prostaglandin system in the monoaminergic control of prolactin release in the rat].
    Costa G; Trovato A; Abate F; De Pasquale R; Galati EM
    Boll Soc Ital Biol Sper; 1979 Aug; 55(15):1492-7. PubMed ID: 261818
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Central 5-hydroxytryptamine2 receptors are involved in the adrenal catecholamine-releasing and hyperglycemic effects of the 5-hydroxytryptamine indirect agonist d-fenfluramine in the conscious rat.
    Chaouloff F; Gunn SH; Young JB
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1008-16. PubMed ID: 1545373
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tandospirone stimulates prolactin secretion in the rat by an action at serotonin-1A receptors.
    Mulroney SE; Skudlarek C; Shemer A; Lumpkin MD; Kellar KJ
    J Pharmacol Exp Ther; 1994 Feb; 268(2):862-7. PubMed ID: 8113999
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of selective serotonin receptor agonists on prolactin secretion in male rats.
    Jørgensen H; Knigge U; Warberg J
    Neuroendocrinology; 1993 Mar; 57(3):401-7. PubMed ID: 8321411
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of metergoline on serum prolactin stimulated by TRH.
    Iannotta F; Gadaleta G; Pollini C; Vettaro MP
    J Endocrinol Invest; 1980; 3(3):301-3. PubMed ID: 6776182
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fenfluramine-induced hyperthermia and stimulation in the rabbit.
    Quock RM; Beal GA
    Res Commun Chem Pathol Pharmacol; 1976 Mar; 13(3):401-9. PubMed ID: 935632
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fenfluramine-induced pulmonary vasoconstriction: role of serotonin receptors and potassium channels.
    Belohlávková S; Simák J; Kokesová A; Hnilicková O; Hampl V
    J Appl Physiol (1985); 2001 Aug; 91(2):755-61. PubMed ID: 11457791
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 5-HT2a/2c receptor blockade by amesergide fully attenuates prolactin response to d-fenfluramine challenge in physically healthy human subjects.
    Coccaro EF; Kavoussi RJ; Oakes M; Cooper TB; Hauger R
    Psychopharmacology (Berl); 1996 Jul; 126(1):24-30. PubMed ID: 8853213
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of fenfluramine on growth hormone and prolactin secretion in obese subjects.
    Altomonte L; Zoli A; Alessi F; Ghirlanda G; Manna R; Greco AV
    Horm Res; 1987; 27(4):190-4. PubMed ID: 3436616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo correlates of central serotonin function after high-dose fenfluramine administration.
    Baumann MH; Ayestas MA; Rothman RB
    Ann N Y Acad Sci; 1998 May; 844():138-52. PubMed ID: 9668672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.